Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups
Viral Immunology · 2025
DOI: 10.1177/08828245251385895 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2025. Verfasst von Soolmaz Khansalar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Interleukin-1. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Interleukin-37 (IL-37) can prevent liver damage and may be an important candidate for use as a novel therapeutic tool in hepatitis B virus (HBV) infection. This study aimed to evaluate the serum levels of IL-37 in individuals with chronic HBV (CHB) infection, those who spontaneously cleared (SC) HBV infection, compared with healthy control (HC) subjects. Materials and Methods: This case-control study included 30 patients with CHB (17 males, 13 females; mean age, 50.13 ± 14.51), 30 subjects with SC HBV infection (16 males, 14 females; mean age, 51.50 ± 16.85), and 42 HC subjects (22 males, 20 females; mean age, 53.52 ± 14.44). Blood samples were collected, and then serum IL-37 levels were measured using an enzyme-linked immunosorbent assay kit.
Results
Our results showed that serum IL-37 levels were significantly higher in the CHB (96.99 ± 13.39 pg/mL) than in the HC group (37.85 ± 2.99 pg/mL, p = 0.02). No statistically significant differences were found in IL-37 serum levels between CHB group and SC group (91.93 ± 17.11 pg/mL, p = 0.43). Correlation analysis showed a significant negative correlation between serum IL-37 levels and age in SC subjects ( p = 0.02, R = −0.42).
Conclusion
Our results suggest that increased production of IL-37 may biologically act as a negative feedback loop to attenuate the release of pro-inflammatory cytokines and subsequently alleviate disease symptoms in CHB. The negative correlation between the cytokine and age may indicate that higher levels of IL-37 in younger individuals may lead to the spontaneous clearance of HBV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Khansalar, S., Rostami, E., Khademolhosseini, A., Bayat, M., Molaei, V., Sarvari, J., & Haghshenas, M. R. (2025). Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups. Viral Immunology. https://doi.org/10.1177/08828245251385895
Vancouver
Khansalar S, Rostami E, Khademolhosseini A, Bayat M, Molaei V, Sarvari J, et al. Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups. Viral Immunology. 2025. doi:10.1177/08828245251385895
BibTeX
@article{Khansalar2025,
author = {Khansalar, Soolmaz and Rostami, Erfan and Khademolhosseini, Aida and Bayat, Maryam and Molaei, Vahid and Sarvari, Jamal and Haghshenas, Mohammad Reza},
title = {Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups},
journal = {Viral Immunology},
year = {2025},
doi = {10.1177/08828245251385895}
}
EUVIMED